For the people leading communication and marketing efforts in the pharmaceutical industry, enhancing the performance of their brands means ensuring maximum return on investment, however long that return takes.
Achieving this takes more than simply carrying out clever marketing campaigns. Strategies need to be carefully considered to ensure content triggers the right emotions in target audiences to drive them to take the desired action.
How can marketers deliver this for their companies? Can behavioral economics, combined with AI (artificial intelligence) help?
Roy Rogers, Director at Research Partnership, an Inizio Advisory company, explores how understanding behavioral economics is essential to delivering more effective brand performance for pharmaceutical companies.
To find out more, click here.
Jump to a slide with the slide dots.
Pharma leaders harness data & AI for insights, but confidence requires a strong foundation. Learn why pausing can drive better decisions.
Read moreUnlock the potential of data and AI with InizioNavigator.ai, combining pharma expertise and advanced tools to solve key challenges and innovation.
Read moreWhile significant progress has been made in focusing on patient needs, our experts emphasize that much still needs to be done.
Read more